Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75443.50 983.97 (1.32%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
61	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	42,073 Mid Cap	2,536.70 (2.14%)	39.39	16.69	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Ipca Laboratories Ltd.	Q V+ PT	48,907 Mid Cap	1,963.55 (1.86%)	39.32	5.86	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Senores Pharmaceuticals Ltd.	Q V PT	5,221 Small Cap	1,127.20 (-0.56%)	39.11	5.21	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Sun Pharmaceutical Industries Ltd.	Q V PT	4,26,662 Large Cap	1,766.80 (-0.64%)	38.91	4.78	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	RPG Life Sciences Ltd.	Q V+ PT	4,255 Small Cap	2,525.50 (-1.82%)	38.89	6.19	42.67	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Ind-Swift Laboratories Ltd.	Q V+ PT	3,246 Small Cap	359.50 (-2.15%)	38.85	2.16	-6.14	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Cipla Ltd.	Q V PT	1,11,489 Large Cap	1,377.90 (-0.15%)	38.48	3.15	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Innova Captab Ltd.	Q V PT	5,900 Small Cap	1,017.35 (-1.33%)	37.75	5.2	31.75	26.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Aurobindo Pharma Ltd.	Q V+ PT	96,537 Mid Cap	1,670.40 (-0.44%)	37.23	4.12	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Park Medi World Ltd.	Q V PT	9,513 Small Cap	223.20 (1.34%)	36.86	4.53	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Glenmark Pharmaceuticals Ltd.	Q V+ PT	65,137 Mid Cap	2,386.60 (3.41%)	36.23	5.94	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Emcure Pharmaceuticals Ltd.	Q V PT	35,440 Small Cap	1,875.70 (0.41%)	35.04	6.78	8.73	13.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Ajanta Pharma Ltd.	Q V+ PT	43,891 Mid Cap	3,393.40 (-3.39%)	34.76	9.03	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Indegene Ltd.	Q V+ PT	14,164 Small Cap	620.05 (5.51%)	34.45	4.22	29.44	13.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Abbott India Ltd.	Q V PT	54,384 Mid Cap	25,665.05 (0.28%)	33.68	10.51	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Shalby Ltd.	Q V+ PT	1,306 Small Cap	122.60 (1.41%)	33.22	1.29	21.51	-5.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Medicamen Biotech Ltd.	Q V+ PT	359 Small Cap	256.85 (0.53%)	33.18	1.26	11.90	-6.38	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Morepen Laboratories Ltd.	Q V+ PT	6,230 Small Cap	108.05 (-4.97%)	33.04	4.51	8.73	-11.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Aarti Pharmalabs Ltd.	Q V+ PT	7,922 Small Cap	890.40 (1.92%)	32.61	3.77	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Laxmi Dental Ltd.	Q V PT	978 Small Cap	179.35 (0.90%)	31.67	3.99	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Gaudium IVF and Women Health Ltd.	Q V PT	770 Small Cap	106.15 (0.38%)	31.47	5	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Advanced Enzyme Technologies Ltd.	Q V+ PT	2,944 Small Cap	279 (6.10%)	29.56	4.15	9.82	13.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Alkem Laboratories Ltd.	Q V PT	61,277 Mid Cap	5,089.40 (-0.69%)	28.4	4.28	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	NGL Fine-Chem Ltd.	Q V PT	1,576 Small Cap	2,557.20 (0.24%)	27.55	4.53	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Zydus Lifesciences Ltd.	Q V PT	1,24,089 Mid Cap	1,237.50 (-0.52%)	27.5	4.6	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Windlas Biotech Ltd.	Q V PT	1,810 Small Cap	869.25 (-0.91%)	27.24	3.52	16.15	12.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Vimta Labs Ltd.	Q V+ PT	2,167 Small Cap	488.30 (0.71%)	26.97	4.41	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Marksans Pharma Ltd.	Q V+ PT	13,896 Small Cap	310.45 (1.24%)	26.89	4.37	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Amrutanjan Health Care Ltd.	Q V+ PT	1,436 Small Cap	497.10 (0.05%)	26.61	3.83	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Caplin Point Laboratories Ltd.	Q V PT	17,672 Small Cap	2,342.70 (0.77%)	26.56	4.81	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,841	7.05%
Advanced Enzyme Tech	279	6.10%
Indegene	620.05	5.51%
Themis Medicare	99.50	4.74%
Max Healthcare Inst.	900.10	4.66%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	24.92	-5.61%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,187	-4.68%
Strides Pharma Scien	1,032	-3.47%
Anlon Healthcare	25.04	-3.40%

News about Top Pharma Companies in India

Nov, 2026

Advanced Enzyme Tech - Quaterly Results

The revenue zoomed 18.51% to Rs. 1371.68 millions for the quarter ended September 2026 as compared to Rs. 1157.48 millions during the corresponding quarter last year.Handsome Net Profit growth of 87.17% reported above the corresponding previous quarter figure of Rs. 417.05 millions to Rs. 222.82 millions.Operating profit for the quarter ended September 2026 rose to 543.16 millions as compared to 326.70 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1371.68	1157.48	18.51	2530.25	2407.72	5.09	4527.66	3514.11	28.84
Other Income	163.97	30.79	432.54	186.84	569.31	-67.18	633.88	614.90	3.09
PBIDT	543.16	326.70	66.26	870.15	1170.48	-25.66	1738.22	1321.69	31.51
Interest	0.31	0.49	-36.73	0.68	1.02	-33.33	2.07	2.36	-12.29
PBDT	542.85	326.21	66.41	869.47	1169.46	-25.65	1697.57	1319.33	28.67
Depreciation	31.73	30.02	5.70	60.94	59.31	2.75	120.83	114.05	5.94
PBT	511.12	296.19	72.56	808.53	1110.15	-27.17	1576.74	1205.28	30.82
TAX	94.07	73.37	28.21	168.02	147.52	13.90	258.68	181.08	42.85
Deferred Tax	1.25	0.54	131.48	8.56	0.28	2957.14	-12.01	12.22	-198.28
PAT	417.05	222.82	87.17	640.51	962.63	-33.46	1318.06	1024.20	28.69
Equity	220.53	223.76	-1.44	223.95	223.76	0.08	223.85	223.76	0.04
PBIDTM(%)	39.60	28.23	40.29	34.39	48.61	-29.26	38.39	37.61	2.07

Oct, 2026

Advanced Enzyme Technologies informs about outcome of board meeting

Advanced Enzyme Technologies has informed that the Board of Directors at its meeting held on October 31, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Indegene informs about newspaper advertisement

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indegene has informed that it enclosed copies of the newspaper advertisement published in Financial Express (English) and Vishwavani (Kannada) today, relating to financial results for 2nd quarter and half year ended September 30, 2026. The above information will be made available on the website of the Company: https://www.indegene.com/.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Vimta Labs - Quaterly Results

A fair growth of 9.95% in the revenue at Rs. 1119.83 millions was reported in the September 2026 quarter as compared to Rs. 1018.48 millions during year-ago period.A meek growth of 3.48% was reported for the quarter ended September 2026 to Rs. 206.14 millions from Rs. 199.20 millions.Operating profit surged to 407.78 millions from the corresponding previous quarter of 368.88 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1119.83	1018.48	9.95	2210.57	1994.12	10.85	4072.90	3439.82	18.40
Other Income	29.04	26.58	9.26	67.16	44.07	52.39	89.89	42.40	112.00
PBIDT	407.78	368.88	10.55	819.01	723.27	13.24	1505.08	1261.89	19.27
Interest	3.85	3.74	2.94	6.22	6.89	-9.72	11.67	19.00	-38.58
PBDT	403.93	365.14	10.62	812.79	716.38	13.46	1477.25	1242.89	18.86
Depreciation	128.68	102.40	25.66	254.16	201.02	26.44	437.72	352.89	24.04
PBT	275.25	262.74	4.76	558.63	515.36	8.40	1039.53	890.00	16.80
TAX	69.11	63.54	8.77	142.07	127.22	11.67	264.41	222.45	18.86
Deferred Tax	1.58	-3.17	-149.84	16.02	-7.23	-321.58	-1.07	12.66	-108.45
PAT	206.14	199.20	3.48	416.56	388.14	7.32	775.12	667.55	16.11
Equity	89.40	89.08	0.36	89.40	89.08	0.36	89.34	44.47	100.90
PBIDTM(%)	36.41	36.22	0.54	37.05	36.27	2.15	36.95	36.68	0.73

Oct, 2026

Sun Pharma. Inds. - Quaterly Results

The sales surged to Rs. 61419.20 millions, up 35.04% for the September 2026 quarter as against Rs. 45481.10 millions during the corresponding quarter previous year.Profit after tax for the quarter ended September 2026 reported a huge growth of 54.42% to Rs. 8712.90 millions from Rs. 5642.20 millions.Operating Profit saw a handsome growth to 17957.40 millions from 12563.80 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	61419.20	45481.10	35.04	118830.50	101429.90	17.16	207546.40	229774.00	-9.67
Other Income	810.10	727.90	11.29	2211.80	1765.00	25.31	4193.30	3791.40	10.60
PBIDT	17957.40	12563.80	42.93	39001.20	32696.20	19.28	66000.20	72168.40	-8.55
Interest	2769.60	2483.30	11.53	5554.40	4867.50	14.11	9478.40	9538.90	-0.63
PBDT	15187.80	10080.50	50.67	33131.50	24952.30	32.78	51058.40	62629.50	-18.48
Depreciation	3157.90	3363.00	-6.10	6237.10	6472.20	-3.63	13117.20	12867.40	1.94
PBT	12029.90	6717.50	79.08	26894.40	18480.10	45.53	37941.20	49762.10	-23.75
TAX	3317.00	1075.30	208.47	7030.10	5387.30	30.49	11707.00	7481.30	56.48
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	8712.90	5642.20	54.42	19864.30	13092.80	51.72	26234.20	42280.80	-37.95
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	29.24	27.62	5.84	32.82	32.24	1.82	31.80	31.41	1.25

Oct, 2026

Ajanta Pharma - Quaterly Results

The sales moved up 41.37% to Rs. 17250.70 millions for the September 2026 quarter as compared to Rs. 12202.40 millions during the year-ago period.Profit after tax for the quarter ended September 2026 reported a huge growth of 52.24% to Rs. 3798.90 millions from Rs. 2495.30 millions.Operating Profit saw a handsome growth to 5697.10 millions from 3646.20 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	17250.70	12202.40	41.37	32137.40	24288.00	32.32	48459.20	43220.40	12.12
Other Income	526.20	750.30	-29.87	1234.40	1156.60	6.73	2044.00	1198.70	70.52
PBIDT	5697.10	3646.20	56.25	10372.30	7346.50	41.19	14023.90	13245.90	5.87
Interest	7.90	7.30	8.22	15.50	14.60	6.16	25.90	46.00	-43.70
PBDT	5689.20	3638.90	56.34	10356.80	7331.90	41.26	13998.00	13199.90	6.05
Depreciation	463.00	419.20	10.45	896.10	822.30	8.97	1687.70	1399.30	20.61
PBT	5226.20	3219.70	62.32	9460.70	6509.60	45.33	12310.30	11800.60	4.32
TAX	1427.30	724.40	97.03	2507.10	1464.60	71.18	2842.10	2631.70	7.99
Deferred Tax	-158.10	64.70	-344.36	-94.60	97.60	-196.93	76.00	51.40	47.86
PAT	3798.90	2495.30	52.24	6953.60	5045.00	37.83	9468.20	9168.90	3.26
Equity	250.70	250.70	0.00	250.70	250.70	0.00	250.70	250.70	0.00
PBIDTM(%)	33.03	29.88	10.52	32.27	30.25	6.70	28.94	30.65	-5.57

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Biocon Ltd.	57,365 Crore
2	Orchid Pharma Ltd.	4,989 Crore
3	Healthcare Global Enterprises Ltd.	8,731 Crore
4	Aster DM Quality Care Ltd.	59,570 Crore
5	Cohance Lifesciences Ltd.	17,005 Crore
6	Krishna Institute of Medical Sciences Ltd	29,480 Crore
7	Dishman Carbogen Amcis Ltd.	2,276 Crore
8	Tarsons Products Ltd.	1,552 Crore
9	Sai Parenterals Ltd.	2,302 Crore
10	Dr. Agarwals Health Care Ltd.	16,117 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,665	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,600	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,387	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,026	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,393	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,385	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,549	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,077	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,670	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,964	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,549	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,393	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,238	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,077	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,549	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,026	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,387	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,665	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,359	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Advanced Enzyme Tech - Quaterly Results

Advanced Enzyme Technologies informs about outcome of board meeting

Indegene informs about newspaper advertisement

Vimta Labs - Quaterly Results

Sun Pharma. Inds. - Quaterly Results

Ajanta Pharma - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?